首页> 外文期刊>Scientific reports. >Relational Network for Knowledge Discovery through Heterogeneous Biomedical and Clinical Features
【24h】

Relational Network for Knowledge Discovery through Heterogeneous Biomedical and Clinical Features

机译:通过异质生物医学和临床特征来实现知识发现的关系网络

获取原文
获取外文期刊封面目录资料

摘要

Biomedical big data, as a whole, covers numerous features, while each dataset specifically delineates part of them. "Full feature spectrum" knowledge discovery across heterogeneous data sources remains a major challenge. We developed a method called bootstrapping for unified feature association measurement (BUFAM) for pairwise association analysis, and relational dependency network (RDN) modeling for global module detection on features across breast cancer cohorts. Discovered knowledge was cross-validated using data from Wake Forest Baptist Medical Center's electronic medical records and annotated with BioCarta signaling signatures. The clinical potential of the discovered modules was exhibited by stratifying patients for drug responses. A series of discovered associations provided new insights into breast cancer, such as the effects of patient's cultural background on preferences for surgical procedure. We also discovered two groups of highly associated features, the HER2 and the ER modules, each of which described how phenotypes were associated with molecular signatures, diagnostic features, and clinical decisions. The discovered "ER module", which was dominated by cancer immunity, was used as an example for patient stratification and prediction of drug responses to tamoxifen and chemotherapy. BUFAM-derived RDN modeling demonstrated unique ability to discover clinically meaningful and actionable knowledge across highly heterogeneous biomedical big data sets.
机译:生物医学大数据作为一个整体涵盖了众多功能,而每个数据集专门描绘了其中的一部分。 “完全特征频谱”知识发现,异构数据源仍然是一个重大挑战。我们开发了一种称为统一特征关联测量(BUFAM)的统一特征关联测量(BUFAM)的方法,以及用于全球模块检测的关系依赖网络(RDN)模型,患乳腺癌队列的特征。发现知识通过来自Wake Forest Baptist Medical Center的电子医疗记录的电子医疗记录的数据交叉验证,并用Biocarta信号传导签名进行注释。发现模块的临床潜力是通过分层患者进行药物反应。一系列发现的关联提供了新的患者患乳腺癌的洞察力,例如患者文化背景对外科手术的偏好的影响。我们还发现了两组高度相关的特征,HER2和ER模块,其中每个都描述了表型如何与分子签名,诊断特征和临床决策相关。被发现的“ER模块”,其主要由癌症免疫力占据,用作患者分层和对他莫莫昔芬和化疗的药物反应预测的示例。 BUFAM衍生的RDN建模展示了在高度异构的生物医学大数据集中发现临床有意义和可操作知识的独特能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号